{
    "2018-07-18": [
        [
            {
                "time": "2018-03-15",
                "original_text": "Drugmakers Game the Patent System and Reap Billions, FDA Says",
                "features": {
                    "keywords": [
                        "Drugmakers",
                        "Patent",
                        "System",
                        "Billions",
                        "FDA"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-04-10",
                "original_text": "FDA Blasts Drugmakers Thwarting Competition on Costly Biologics",
                "features": {
                    "keywords": [
                        "FDA",
                        "Drugmakers",
                        "Competition",
                        "Biologics"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-05-20",
                "original_text": "AbbVie Settles With Mylan to Delay Humira Biosimilar in U.S.",
                "features": {
                    "keywords": [
                        "AbbVie",
                        "Mylan",
                        "Humira",
                        "Biosimilar",
                        "Delay"
                    ],
                    "sentiment_score": -0.4,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-06-12",
                "original_text": "What's Behind Johnson & Johnson's Double-Digit Growth?",
                "features": {
                    "keywords": [
                        "Johnson & Johnson",
                        "Double-Digit",
                        "Growth"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}